These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat. Ashida SI, Abiko Y. Thromb Haemost; 1979 Apr 23; 41(2):436-49. PubMed ID: 224522 [Abstract] [Full Text] [Related]
5. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases. Manns JM, Brenna KJ, Colman RW, Sheth SB. Thromb Haemost; 2002 May 23; 87(5):873-9. PubMed ID: 12038792 [Abstract] [Full Text] [Related]
6. Lithium inhibits adenylate cyclase of human platelets. Imandt L, Tijhuis D, Wessels H, Haanen C. Thromb Haemost; 1981 Apr 30; 45(2):142-5. PubMed ID: 6266068 [Abstract] [Full Text] [Related]
7. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC, Liao CH, Chang YW, Liou JT, Day YJ. Biochem Pharmacol; 2009 Apr 15; 77(8):1364-73. PubMed ID: 19426675 [Abstract] [Full Text] [Related]
13. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function. Salzman EW, Levine L. J Clin Invest; 1971 Jan 15; 50(1):131-41. PubMed ID: 4322665 [Abstract] [Full Text] [Related]
14. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets. Lam SC, Guccione MA, Packham MA, Mustard JF. Thromb Haemost; 1982 Apr 30; 47(2):90-5. PubMed ID: 6285543 [Abstract] [Full Text] [Related]
15. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism. Hashimoto S, Shibata S, Kobayashi B. Thromb Haemost; 1978 Feb 28; 39(1):177-85. PubMed ID: 205972 [Abstract] [Full Text] [Related]
16. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography. Janka HU, Standl E, Mehnert H. Horm Metab Res Suppl; 1981 Feb 28; 11():26-9. PubMed ID: 6172351 [Abstract] [Full Text] [Related]
17. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW. Biochem Pharmacol; 2004 Apr 15; 67(8):1559-67. PubMed ID: 15041473 [Abstract] [Full Text] [Related]
18. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation. Hagiwara M, Endo T, Kanayama T, Hidaka H. J Pharmacol Exp Ther; 1984 Feb 15; 228(2):467-71. PubMed ID: 6141286 [Abstract] [Full Text] [Related]
19. Splitomicin suppresses human platelet aggregation via inhibition of cyclic AMP phosphodiesterase and intracellular Ca++ release. Liu FC, Liao CH, Chang YW, Liou JT, Day YJ. Thromb Res; 2009 Jun 15; 124(2):199-207. PubMed ID: 19327818 [Abstract] [Full Text] [Related]
20. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. Dell'Agli M, Maschi O, Galli GV, Fagnani R, Dal Cero E, Caruso D, Bosisio E. Br J Nutr; 2008 May 15; 99(5):945-51. PubMed ID: 17927845 [Abstract] [Full Text] [Related] Page: [Next] [New Search]